The latest news from oncology events around the world
Results from two Phase III trials presented at the 2026 ESMO Gastrointestinal Cancers Congress have…
The combination of adagrasib and cetuximab did not significantly improve progression-free survival (PFS) or overall…
ASCO Special Part 2: Quick Bite Marathon! The Oncology Journal Club Podcast hosted by Professor…
Longer lifetime exposure to female hormones may increase the risk of thyroid cancer in women, according to…
The report “Lancet Oncology Commission on Cancer Workforce: A Global Crisis” was launched at the…
The CAPTURE breast cancer clinical trial has concluded that current standard of care, chemotherapy with…
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained…
The report “Lancet Oncology Commission on Cancer Workforce: A Global Crisis” was launched at the…
A digital symptom monitoring program supported by palliative care nurses helped maintain quality of life…
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained…